|
Match
|
Document |
Document Title |
|
|
6627220 |
Tablets containing heat sensitive materials and method for forming thereof
The present invention provides a process and apparatus for preserving the potency of a tableted heat sensitive ingredient. The process includes the steps of forming the ingredient into a tablet and...
|
|
|
6627228 |
Polymeric delivery agents and delivery agents compounds
Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are...
|
|
|
6627221 |
Pharmaceutical composition containing diphosphonic acid or salt thereof
The invention relates to a solid pharmaceutical form of administration containing a diphosphonic acid or a physiologically compatible salt thereof as the active substance, wherein the active...
|
|
|
6627222 |
Amoxicillin-dicloxacillin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or dicloxacillin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and dicloxacillin being...
|
|
|
6623754 |
Dosage form of N-acetyl cysteine
A directly-compressed, controlled release tablet contains N-acetyl cysteine as the active ingredient.
|
|
|
6623756 |
Directly compressed solid dosage articles
Solid dosage articles such as pharmaceutical tablets for the controlled release of a desired compound such as an active ingredient are directly compressed from a flowable, compressible mixture of...
|
|
|
6623755 |
Pharmaceutical tablets
The present invention relates to novel pharmaceutical tablets useful for administering pharmaceutical active ingredients, such as bisphosphonates. These tablets have improved surface properties...
|
|
|
6620433 |
Dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications
The new galenic formulation of paracetamol is comprised of a base mixture of paracetamol and citric acid in a proportion of 85:15 to 90:10 w/w among other pharmaceutically acceptable components, in...
|
|
|
6620791 |
Edible compositions containing trehalose
The invention provides edible compositions such as solid particulate sweeteners, boiled sweets, chocolate and chewing gum, wherein the compositions comprise at least 10% on a dry weight basis of...
|
|
|
6613346 |
Chewable product including active ingredient
Products and methods of delivering medicaments are provided. The product includes a chewing gum center including a compressible powder that is compressed around the center. The powder includes a...
|
|
|
6610328 |
Amoxicillin-clarithromycin antibiotic composition
An antibiotic product for delivering at least Amoxicillin or Clarithromycin that is comprised of three dosage forms with different release profiles with each of Amoxicillin and Clarithromycin being...
|
|
|
6610327 |
Pharmaceutical moxifloxacin preparation
The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the...
|
|
|
6610325 |
Tablets to be crunched or sucked, comprising iron as active principle
This pharmaceutical medicine comprises an iron salt, not less than two polyols, a binding agent, a lubricating agent, and a flavoring agent. The dose of elemental iron is not less than 5 mg, and...
|
|
|
6607750 |
Directly compressible acetaminophen compositions
Acetaminophen compositions are disclosed which are capable of being directly compressed, without addition of other components, into an tablet dosage form, and which include, based on the total...
|
|
|
6605301 |
Dispersible macrolide compounds and method for production thereof
The invention relates to dispersible tablets containing macrolides as active ingredients either on their own or associated with other active ingredients, in addition to a method for the production...
|
|
|
6602520 |
Method for producing quickly decomposable solid pharmaceutical preparations
Rapidly disintegrating preparations containing at least one active pharmaceutical ingredient and at least one excipient can be obtained by a simple process in which at least the predominant part of...
|
|
|
6599531 |
Method of making ibuprofen and narcotic analgesic compositions
Provided herein are compositions and methods of making compositions of ibuprofen in combination with a narcotic analgesic. Specifically provided is a pharmaceutical tablet composition comprising...
|
|
|
6599522 |
Triglyceride reducing agent
The use of vanillin as a hypolipidemic—a hypotriglyceridemic pharmaceutical agent over a wide range of concentration in the treatment of diabetes (type-2), cardiovascular disturbances, and...
|
|
|
6599530 |
Oral compacted composition comprising catechol derivatives
The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and croscarmellose sodium. The composition is...
|
|
|
6599931 |
Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone
A test system for characterizing the compatibility of bioactive substances with polyvinylpyrrolidones in a solid dispersion consisting of one or more bioactive substances and...
|
|
|
6596312 |
Hydrolyzed cellulose granulations of salts of drugs
The present invention provides a method for preparing a spray-dried, compressible granular formulation for preparing pharmaceutical tablets in which essentially water-insoluble, acidic, amphoteric,...
|
|
|
6592901 |
Highly compressible ethylcellulose for tableting
A pharmaceutical dosage form composition is composed of an ethylcellulose that has an ethoxyl range lower limit of 49.6%, an a viscosity of less than 53 cps and at least one active pharmaceutical...
|
|
|
6589554 |
Tablets quickly disintegrating in the oral cavity and process for producing the same
The present invention relates to a quick disintegrating tablet in buccal cavity, comprising: a mixture, comprising a drug, a sugar (A), and an amorphous sugar (B), and after it is forming a tablet,...
|
|
|
6586005 |
Extended release formulation of etodolac
A sustained release formulation of etodolac for once daily administration is described.
|
|
|
6586004 |
Solid preparation
A solid preparation which comprises (i) a pharmaceutically active ingredient, (ii) one or more water-soluble sugar alcohol selected from the group consisting of sorbitol, maltitol, reduced starch...
|
|
|
6582734 |
Antimicrobial composition useful for the treatment of bovine mastitis
The present invention relates to a two-part antimicrobial composition comprising at least one chlorine dioxide generating component comprising at least one metal chlorite and at least one...
|
|
|
6583160 |
Nicotine therapy method and oral carrier for assuaging tobacco-addiction
A method for assuaging tobacco addiction comprises pulsing doses of nicotine into a user's bloodstream so it reaches the brain before passing through the liver. A nicotine-burst tablet is held in...
|
|
|
6576260 |
Sustained-release form of administration containing tramadol saccharinate
Disclosed herein is sustained-release formulations of tramadol comprising tramadol saccharinate coated with at least one sustained-release coating. The sustained release formulations may also...
|
|
|
6576256 |
Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
Methods and compositions are provided for reducing the risk of cardiovascular events in individuals who are at elevated cardiovascular risk, including individuals who have systemic lupus...
|
|
|
6576259 |
Sustained release formulations containing tacrolimus
Sustained release formulation containing tacrolimus or its hydrate is provided. The time (T63.2%) required for 63.2% of the maximum amount of tacrolimus or its hydrate to be dissolved is 0.7 to 15...
|
|
|
6572888 |
Controlled release lipoic acid
A controlled release formulation of lipoic acid is disclosed. The lipoic acid is combined with excipient materials in such a way that those materials provide for gradual release of the lipoic acid...
|
|
|
6572886 |
Dextrose-based lozenges and process for their manufacture
The invention relates to lozenges comprising a sweetening component and a binder, wherein more than 50% of the sweetening component consists of dextrose, this percentage being expressed by weight,...
|
|
|
6572887 |
Polysaccharide material for direct compression
This invention relates to a method of using compressible polysaccharides having a tap density of less than 0.4 g/ml as a filler/binder for tablets prepared by direct compression, excipient blends...
|
|
|
6572889 |
Controlled release solid dosage carbamazepine formulations
A polymer or copolymer composition derived from one or more unsaturated carboxylic acids that is cross-linked and carbamazepine in conjunction with conventional materials such as fillers,...
|
|
|
6569454 |
Simple tablet compression using gelatin
The present invention comprises a method of tablet preparation. The invention provides a simple and cost effective method to compress good tablets.
|
|
|
6569455 |
Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates
The present invention relates to stable quick-release extrudates that contain low-viscosity hydroxypropylcellulose and at least one active ingredient. This invention also relates to a method for...
|
|
|
6569461 |
Dihydroxy open-acid and salts of HMG-CoA reductase inhibitors
The instant invention provides methods and pharmaceutical compositions for inhibiting HMG-CoA reductase, as well as for treating and/or reducing the risk for diseases and conditions affected by...
|
|
|
6569463 |
Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions
The present invention provides solid pharmaceutical compositions for improved delivery of a wide variety of pharmaceutical active ingredients contained therein or separately administered. In one...
|
|
|
6565877 |
Taste masked compositions
A taste masked composition which comprises a bitter tasting drug, a combination of two enteric polymers comprising, a methacrylic acid copolymer and a phthalate polymer is described. The...
|
|
|
6565880 |
Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-&lsqb 4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl&rsqb -urea
A formulation comprising, and process for preparing, improved oral dosage forms of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin
-4-yl-ethoxy)-naphthalen-1-yl]-urea, a chemical...
|
|
|
6562375 |
Stable pharmaceutical composition for oral use
The present invention is to provide a stable pharmaceutical composition for oral use and preparation thereof in which changes are prevented in drug release at stored even under the exposure to...
|
|
|
6562372 |
Tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
A tocotrienol-containing powder prepared by a process wherein an oil containing a tocotrienol is treated with a lecithin, a cellulose and an emulsifying agent in water to form an emulsion, a powder...
|
|
|
6558699 |
High drug load immediate and modified release oral dosage formulations and processes for their manufacture
This invention relates to high drug load granulation of (E)-α-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-
yl]methylene-2-thiophenepropionic acid in the anhydrous form, a process for its...
|
|
|
6555133 |
Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
The present invention provides improved oral dosage form formulations of efavirenz that are useful in the inhibition of human immunodeficiency virus (HIV), the prevention or treatment of infection...
|
|
|
6555581 |
Levothyroxine compositions and methods
The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized...
|
|
|
6555138 |
Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
A drug delivery system for oral administration in solid dry form of greasy/oily/sticky substance(s) and pharmaceutically active substance(s) or pharmaceutically active substance(s) which...
|
|
|
6555136 |
Pharmaceutical dosage form for pulsatile delivery of methylphenidate
Novel pharmaceutical dosage forms provide for pulsatile delivery of methylphenidate, i.e., release encapsulated drug in spaced apart “pulses.” The dosage forms are comprised of first, second...
|
|
|
6548086 |
Pharmaceutical composition comprising extract from plant Cryptolepis buchanani for treating immunodeficiency
Pharmaceutical composition and a method useful for treating immunodeficiency in animals or human beings, said composition comprising effective amount of the extract obtained from any part of plant ...
|
|
|
6548082 |
Methods for treating apnea and apnea disorders using optically pure R(&plus ) ondansetron
Methods for the treatment, management, or prevention of apnea and apnea disorders, or symptoms thereof, using a therapeutically effective amount of substantially optically pure R(+) ondansetron, or...
|
|
|
6544556 |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
An oral solid dosage form includes a therapeutically effective amount of an NSAID and a proton pump inhibitor in an amount effective to inhibit or prevent gastrointestinal side effects normally...
|